Skip to main content

Month: May 2025

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

Awaiting FDA action on YUTREPIA™ NDA with a PDUFA goal date of May 24, 2025 District Court dismissed cross claim filed by United Therapeutics challenging PH-ILD amendment Fully enrolled Cohort A of ASCENT study in patients with PH-ILD Further strengthened financial position via access of up to $100 million from existing financing agreement with HealthCare Royalty Company to host webcast today at 8:30 a.m. ETMORRISVILLE, N.C., May 08, 2025 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today reported financial results for the first quarter ended March 31, 2025. The company will also host a webcast at 8:30 a.m. ET on May 8, 2025 to discuss its financial results and provide a corporate update. Dr. Roger Jeffs,...

Continue reading

Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress

–Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 — –Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second quarter of calendar 2025 — –With positive Phase 2b QUALITY study, Veru plans for end of Phase 2 meeting with FDA to discuss Phase 3 clinical program — –Company to host conference call and webcast today at 8:00 a.m. ET– MIAMI, FL, May 08, 2025 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced financial results for its fiscal 2025 second quarter and provided an update on progress of its clinical development programs. “In addition...

Continue reading

Webuy Global Ltd. (Nasdaq: WBUY) Reinstated Listing on Nasdaq Capital Market and Returns to Profitability with Strong First Quarter Growth in Travel

Singapore, May 08, 2025 (GLOBE NEWSWIRE) — Webuy Global Ltd. (Nasdaq: WBUY), a forward-thinking, technology-driven e-commerce and travel platform in Southeast Asia, today announced that the Company has been successfully reinstated on the Nasdaq Capital Market (“Nasdaq”), effective May 8, 2025. The relisting follows confirmation from Nasdaq that the Company has regained compliance with the minimum bid price requirement under Rule 5550(a)(2). Webuy’s return to Nasdaq  is a pivotal milestone in its broader turnaround. After implementing a comprehensive recovery strategy, which included reverse stock splits and a successful appeal before the Nasdaq Hearing Panel , the company has regained full compliance. This achievement underscores Webuy’s continued operational momentum and hopes to lead to renewed investor confidence in its growth...

Continue reading

Hut 8 Reports First Quarter 2025 Results

ASIC fleet upgrade drives 79% increase in hashrate and 37% improvement in fleet efficiency quarter-over-quarter Launch of American Bitcoin accelerates Hut 8’s evolution as an integrated energy infrastructure platform Earnings Release HighlightsRevenue of $21.8 million, net loss of $134.3 million, and Adjusted EBITDA of ($117.7) million. Total energy capacity under management of 1,020 megawatts (“MW”) as of March 31, 2025. ~10,800 MW development pipeline with ~2,600 MW of capacity under exclusivity as of March 31, 2025. Strategic Bitcoin reserve of 10,264 Bitcoin with a market value of $847.2 million as of March 31, 2025.MIAMI, May 08, 2025 (GLOBE NEWSWIRE) — Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), an energy infrastructure platform integrating power, digital infrastructure, and compute at scale to fuel next-generation,...

Continue reading

Arhaus Reports First Quarter 2025 Financial Results

BOSTON HEIGHTS, Ohio, May 08, 2025 (GLOBE NEWSWIRE) — Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a growing lifestyle brand and omni-channel retailer of premium artisan-crafted home furnishings, reported first quarter 2025 results for the period ended March 31, 2025. Highlights include:Net revenue increased 5.5% to $311 million compared to the same period in 2024 Gross margin increased 0.4% to $116 million compared to the same period in 2024 Selling, general and administrative expenses increased 13.9% to $110 million compared to the same period in 2024 Net and comprehensive income decreased 67.6% to $5 million compared to the same period in 2024 Adjusted EBITDA decreased 36.2% to $19 million compared to the same period in 2024 Comparable growth(1) of (1.5)% Demand comparable growth(2) of 4.1% Total Showroom Projects(3)...

Continue reading

Leiðrétting: Lánasjóður sveitarfélaga – Útboð LSS 39 0303 og LSS151155

Lánasjóður sveitarfélaga hefur ákveðið að efna til útboðs á skuldabréfaflokkunum LSS 39 0303 og LSS151155 mánudaginn 12. maí 2025. Lánasjóðurinn stefnir að því að taka tilboðum að fjárhæð 500 til 1.500 milljónir króna að nafnvirði í skuldabréfaflokknum LSS151155 og að fjárhæð 500 til 1.500 milljónir króna að nafnvirði í skuldabréfaflokknum LSS 39 0303. Lánasjóðurinn áskilur sér rétt til að hækka og lækka útboðsfjárhæð útboðsins, taka hvaða tilboði sem er eða hafna þeim öllum. Lánasjóðurinn hefur boðið aðalmiðlurum sjóðsins Arion banka, Íslandsbanka, Kviku banka, Landsbankanum og Fossum fjárfestingabanka að taka þátt í útboðinu.  Óskað er eftir tilboðum í samræmi við eftirfarandi lýsingu: Fyrirkomulag: “Hollensk” uppboðsaðferð þar sem allir tilboðsgjafar fá sömu ávöxtunarkröfu og hæst er tekið. Heimilt er að afturkalla eða breyta tilboði...

Continue reading

RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2025 REVENUE +11.9%, EBITDA(1) +10.7%, ADJUSTED NET INCOME(2) +7.2%

Consolidated net revenue of € 680.0 million in the first quarter of 2025, +11.9% or +7.2% on a like-for-like basis(3) and at constant exchange rates (CER) EBITDA(1) of € 270.2 million, +10.7%, margin on revenue of 39.7%        Adjusted net income(2) of € 175.5 million, +7.2%Net income of € 125.0 million, +1.2%Free cash flow(4) of € 158.8 million, +€ 11.7 million vs prior year Net debt(5) at € 2,020.8 million, just below 2.2x EBITDA pro-forma(6) Isturisa® granted expanded approval by the FDA for the treatment of endogenous hypercortisolemia in adults with Cushing’s syndrome, supporting peak year sales increase to € 550-650 million; Signifor® LAR approved in China for the treatment of patients with acromegaly FY 2025 financial targets confirmed Positive momentum of the Group expected to continue as reflected in the FY 2027 financial...

Continue reading

Enerflex Ltd. Announces First Quarter 2025 Financial and Operational Results

ADJUSTED EBITDA OF $113 MILLION AND FREE CASH FLOW OF $85 MILLION EI CONTRACT BACKLOG AND ES BACKLOG OF $1.5 BILLION AND $1.2 BILLION, RESPECTIVELY, PROVIDING SOLID OPERATIONAL VISIBILITY REDUCED BANK ADJUSTED NET DEBT-TO-EBITDA RATIO TO 1.3x1 AT THE END OF Q1/25 CALGARY, Alberta, May 08, 2025 (GLOBE NEWSWIRE) — Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) today reported its financial and operational results for the three months ended March 31, 2025. All amounts presented are in U.S. Dollars unless otherwise stated. Q1/25 FINANCIAL AND OPERATIONAL OVERVIEWGenerated revenue of $552 million compared to $638 million in Q1/24 and $561 million in Q4/24.Lower revenue compared with the prior year is primarily attributed to upfront revenue recognized in the Energy Infrastructure (“EI”) product line...

Continue reading

H World Group Limited Schedules First Quarter of 2025 Earnings Release on May 20, 2025

SINGAPORE and SHANGHAI, May 08, 2025 (GLOBE NEWSWIRE) — H World Group Limited (NASDAQ: HTHT and HKEX: 1179) (“H World”, “we” or “our”) a key player in the global hotel industry, today announced that it will schedule to release its unaudited financial results for the first quarter of 2025 on Tuesday, May 20, 2025 (Hong Kong time), after the trading hours of The Stock Exchange of Hong Kong Limited and before the opening of the U.S. market. H World’s management will host a conference call at 8 a.m. (U.S. Eastern time) on Tuesday, May 20, 2025 (or 8 p.m. (Hong Kong time) on Tuesday, May 20, 2025) following the announcement. To join by phone, all participants must pre-register this conference call using the Participant Registration link of https://register-conf.media-server.com/register/BIa8086f3fd2fa4a3aa928220aab5bc4e3. Upon registration,...

Continue reading

First Advantage Reports First Quarter 2025 Results

Reaffirms Full Year 2025 Guidance First Quarter 2025 Highlights1Revenues of $354.6 million Net Loss of $(41.2) million, a net loss margin of (11.6)%, includes $15.3 million of expenses related to the acquisition of Sterling Check Corp. (“Sterling”) and related integration, and $41.2 million of Sterling depreciation and amortization Adjusted Net Income of $30.5 million Adjusted EBITDA of $92.1 million; Adjusted EBITDA Margin of 26.0% GAAP Diluted Net Loss Per Share of $(0.24), includes $0.07 per share of expenses incurred related to the Sterling acquisition and related integration Adjusted Diluted Earnings Per Share of $0.17 Cash Flows from Operations of $19.5 million; Adjusted Operating Cash Flows of $33.3 million, after adjusting for $13.8 million of cash costs directly associated with the Sterling acquisition and related integrationReaffirming...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.